|Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis|
P Ost, BA Jereczek-Fossa, N Van As, T Zilli, A Muacevic, K Olivier, ...
European urology 69 (1), 9-12, 2016
|Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases|
U Schick, S Jorcano, P Nouet, M Rouzaud, H Vees, T Zilli, O Ratib, ...
Acta oncologica 52 (8), 1622-1628, 2013
|[(18) F] Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma|
DC Weber, T Zilli, F Buchegger, N Casanova, G Haller, M Rouzaud, ...
Radiation Oncology 3 (1), 1-11, 2008
|Recurrence pattern after [(18) F] fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study|
DC Weber, N Casanova, T Zilli, F Buchegger, M Rouzaud, P Nouet, ...
Radiotherapy and oncology 93 (3), 586-592, 2009
|Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate cancer nodal recurrences|
P Ost, BA Jereczek-Fossa, N Van As, T Zilli, A Tree, D Henderson, ...
Clinical Oncology 28 (9), e115-e120, 2016
|Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review|
G Mok, E Benz, JP Vallee, R Miralbell, T Zilli
International Journal of Radiation Oncology* Biology* Physics 90 (2), 278-288, 2014
|First imaging results of an intraindividual comparison of 11 C-acetate and 18 F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second …|
F Buchegger, V Garibotto, T Zilli, L Allainmat, S Jorcano, H Vees, O Rager, ...
European journal of nuclear medicine and molecular imaging 41 (1), 68-78, 2014
|Radiotherapy in the time of the Coronavirus pandemic: when less is better|
V Achard, P Tsoutsou, T Zilli
International journal of radiation oncology, biology, physics, 2020
|Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment: a multi-institutional case-control …|
T Steuber, C Jilg, P Tennstedt, A De Bruycker, D Tilki, K Decaestecker, ...
European urology focus 5 (6), 1007-1013, 2019
|Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison …|
DC Weber, T Zilli, JP Vallee, M Rouzaud, R Miralbell, L Cozzi
International Journal of Radiation Oncology* Biology* Physics 84 (3), e311-e318, 2012
|Small cell carcinoma of the urinary bladder: a retrospective, multicenter rare cancer network study of 107 patients|
D Pasquier, B Barney, S Sundar, P Poortmans, S Villa, H Nasrallah, ...
International Journal of Radiation Oncology* Biology* Physics 92 (4), 904-910, 2015
|Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database|
S Salas, N Resseguier, JY Blay, A Le Cesne, A Italiano, C Chevreau, ...
Annals of oncology 28 (8), 1779-1787, 2017
|Node-negative T1–T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?|
T Zilli, U Schick, M Ozsahin, P Gervaz, AD Roth, AS Allal
Radiotherapy and Oncology 102 (1), 62-67, 2012
|Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body …|
E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ...
European urology 76 (6), 732-739, 2019
|Reirradiation of prostate cancer local failures after previous curative radiation therapy: long-term outcome and tolerance|
T Zilli, E Benz, G Dipasquale, M Rouzaud, R Miralbell
International Journal of Radiation Oncology* Biology* Physics 96 (2), 318-322, 2016
|Clinical impact of 68 Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical …|
J Müller, DA Ferraro, UJ Muehlematter, HIG Schüler, S Kedzia, D Eberli, ...
European journal of nuclear medicine and molecular imaging 46 (4), 889-900, 2019
|Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancer|
T Zilli, M Chagnon, T Van Nguyen, JP Bahary, JP Guay, A Dufresne, ...
Cancer 116 (24), 5650-5658, 2010
|Whole-body SPECT/CT versus planar bone scan with targeted SPECT/CT for metastatic workup|
O Rager, R Nkoulou, N Exquis, V Garibotto, C Tabouret-Viaud, H Zaidi, ...
BioMed research international 2017, 2017
|Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis|
T Zilli, D Taussky, D Donath, HP Le, RX Larouche, D Béliveau-Nadeau, ...
International Journal of Radiation Oncology* Biology* Physics 81 (4), e377-e383, 2011
|Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot …|
T Zilli, S Jorcano, M Rouzaud, G Dipasquale, P Nouet, JI Toscas, ...
International Journal of Radiation Oncology* Biology* Physics 81 (2), 382-389, 2011